Bill Text: IL SB1839 | 2019-2020 | 101st General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Pharmacy Practice Act. In provisions exempting from the Act the sale or distribution of dialysate or devices necessary to perform home peritoneal renal dialysis for patients with end-stage renal disease, provides that an agent of the manufacturer who lawfully holds the dialysate or devices may be registered as a manufacturer, third-party logistics provider, or wholesaler (rather than a manufacturer or wholesaler). Amends the Wholesale Drug Distribution Licensing Act. Requires that each resident third-party logistics provider must be licensed by the Department of Financial and Professional Regulation, and every non-resident third-party logistics provider must be licensed in this State, in accordance with the Act, prior to shipping a prescription drug into this State (and removes language requiring a third-party logistics provider to be licensed as a wholesale distributor and, in order to be considered part of the normal distribution channel, to be an authorized distributor of record). Provides that each third-party logistics provider must designate an individual representative who shall serve as the contact person for the Department, and requires the individual representative to provide the Department with certain information. Prohibits a third-party logistics provider from operating from a place of residence, and requires a third-party logistics provider facility to be located apart and separate from any retail pharmacy licensed by the Department. Provides that the Department may not issue a third-party logistics provider license to an applicant, unless the Department first: ensures that a physical inspection of the facility satisfactory to the Department has occurred at the address provided by the applicant; and determines that the designated representative meets specified qualifications. Requires a third-party logistics provider to publicly display all licenses and have the most recent state and federal inspection reports readily available. Makes conforming changes throughout the Act. Provides that an application (rather than application blanks) for renewal of a license shall be mailed or emailed (rather than mailed) to each licensee at least 60 days before the license expires. Effective immediately.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Passed) 2019-08-16 - Public Act . . . . . . . . . 101-0420 [SB1839 Detail]

Download: Illinois-2019-SB1839-Introduced.html


101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020
SB1839

Introduced 2/15/2019, by Sen. Thomas Cullerton

SYNOPSIS AS INTRODUCED:
225 ILCS 120/27

Amends the Wholesale Drug Distribution Licensing Act. Makes a technical change to a Section concerning social security numbers on license applications.
LRB101 09712 JRG 54811 b

A BILL FOR

SB1839LRB101 09712 JRG 54811 b
1 AN ACT concerning regulation.
2 Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4 Section 5. The Wholesale Drug Distribution Licensing Act is
5amended by changing Section 27 as follows:
6 (225 ILCS 120/27)
7 (Section scheduled to be repealed on January 1, 2023)
8 Sec. 27. Social Security Number on license application. In
9addition to any other information required to be contained in
10the the application, every application for an original license
11under this Act shall include the applicant's Social Security
12Number, which shall be retained in the agency's records
13pertaining to the license. As soon as practical, the Department
14shall assign a customer's identification number to each
15applicant for a license.
16 Every application for a renewal or restored license shall
17require the applicant's customer identification number.
18(Source: P.A. 97-400, eff. 1-1-12.)
feedback